HCS
ABVX

Himension Capital (Singapore)’s Abivax ABVX Stock Holding History

Himension Capital (Singapore)’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$612K Sell
4,591
-5,068
-52% -$574K 0.04% 130
2026
Q1 		$1.08M Buy
9,659
+1,909
+25% +$226K 0.08% 74
2025
Q4 		$1.05M Sell
7,750
-4,212
-35% -$460K 0.06% 64
2025
Q3 		$1.02M Buy
+11,962
New +$733K 0.06% 69

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Himension Capital (Singapore)'s ABVX Position: Q2 2026 in Review

Himension Capital (Singapore) reduced its Abivax (ABVX) stake by 52% in Q2 2026, selling an estimated $574K and leaving 4,591 shares worth $612K. The position accounts for 0.04% of the portfolio, ranked #130.

Himension Capital (Singapore) first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.08M in Q1 2026. 303 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Himension Capital (Singapore) held 4,591 shares of Abivax worth $612K as of Q2 2026.
  • Himension Capital (Singapore) sold 5,068 Abivax shares in Q2 2026, an estimated $574K.
  • Abivax made up 0.04% of Himension Capital (Singapore)'s portfolio in Q2 2026, its #130 holding.
  • Himension Capital (Singapore) first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • Himension Capital (Singapore)'s Abivax position peaked at $1.08M in Q1 2026.
  • 303 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Himension Capital (Singapore)'s 13F filing for Q2 2026, filed 13 Aug 2026.